chr7-128850060-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001458.5(FLNC):​c.5284C>T​(p.Arg1762Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000168 in 1,540,606 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1762H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 2 hom. )

Consequence

FLNC
NM_001458.5 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.581

Publications

1 publications found
Variant links:
Genes affected
FLNC (HGNC:3756): (filamin C) This gene encodes one of three related filamin genes, specifically gamma filamin. These filamin proteins crosslink actin filaments into orthogonal networks in cortical cytoplasm and participate in the anchoring of membrane proteins for the actin cytoskeleton. Three functional domains exist in filamin: an N-terminal filamentous actin-binding domain, a C-terminal self-association domain, and a membrane glycoprotein-binding domain. Mutations in this gene are a cause of cardiopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2022]
FLNC-AS1 (HGNC:53474): (FLNC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.031011462).
BP6
Variant 7-128850060-C-T is Benign according to our data. Variant chr7-128850060-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 472100.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000158 (219/1388298) while in subpopulation MID AF = 0.0016 (9/5624). AF 95% confidence interval is 0.000834. There are 2 homozygotes in GnomAdExome4. There are 123 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 40 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNCNM_001458.5 linkc.5284C>T p.Arg1762Cys missense_variant Exon 31 of 48 ENST00000325888.13 NP_001449.3 Q14315-1Q59H94
FLNCNM_001127487.2 linkc.5200-324C>T intron_variant Intron 30 of 46 NP_001120959.1 Q14315-2Q59H94
FLNC-AS1NR_149055.1 linkn.*102G>A downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNCENST00000325888.13 linkc.5284C>T p.Arg1762Cys missense_variant Exon 31 of 48 1 NM_001458.5 ENSP00000327145.8 Q14315-1

Frequencies

GnomAD3 genomes
AF:
0.000263
AC:
40
AN:
152190
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000531
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000285
AC:
41
AN:
143778
AF XY:
0.000321
show subpopulations
Gnomad AFR exome
AF:
0.000392
Gnomad AMR exome
AF:
0.0000403
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000242
Gnomad OTH exome
AF:
0.00116
GnomAD4 exome
AF:
0.000158
AC:
219
AN:
1388298
Hom.:
2
Cov.:
32
AF XY:
0.000179
AC XY:
123
AN XY:
685798
show subpopulations
African (AFR)
AF:
0.000346
AC:
11
AN:
31778
American (AMR)
AF:
0.0000556
AC:
2
AN:
36000
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25194
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36024
South Asian (SAS)
AF:
0.000931
AC:
74
AN:
79490
European-Finnish (FIN)
AF:
0.0000554
AC:
2
AN:
36106
Middle Eastern (MID)
AF:
0.00160
AC:
9
AN:
5624
European-Non Finnish (NFE)
AF:
0.0000870
AC:
94
AN:
1079998
Other (OTH)
AF:
0.000465
AC:
27
AN:
58084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000263
AC:
40
AN:
152308
Hom.:
0
Cov.:
33
AF XY:
0.000282
AC XY:
21
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000529
AC:
22
AN:
41564
American (AMR)
AF:
0.0000653
AC:
1
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68016
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000164
Hom.:
0
Bravo
AF:
0.000302
ESP6500AA
AF:
0.000250
AC:
1
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.000186
AC:
21

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 28, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FLNC: BP4 -

Mar 15, 2023
Revvity Omics, Revvity
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy 26 Uncertain:1
-
Neuberg Centre For Genomic Medicine, NCGM
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The missense variant c.5284C>T (p.Arg1762Cys) in FLNC gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The variant has been submitted to ClinVar with conflicting interpretations of Uncertain Significance/Likely Benign. The p.Arg1762Cys variant is novel (not in any individuals) in 1000 Genomes and allele frequency of 0.02512% is reported in gnomAD. The amino acid Arg at position 1762 is changed to a Cys changing protein sequence and it might alter its composition and physico-chemical properties. In silico tools predict the variant to be tolerated. The residue is conserved across species. The amino acid change p.Arg1762Cys in FLNC is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The cysteine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. For these reasons, this variant has been classified as Uncertain Significance . -

not specified Benign:1
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jan 26, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.35
T
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.54
T
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.031
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.58
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.17
Sift
Benign
0.057
T
Sift4G
Uncertain
0.046
D
Polyphen
0.0
B
Vest4
0.11
MVP
0.26
MPC
0.38
ClinPred
0.018
T
GERP RS
2.5
Varity_R
0.071
gMVP
0.33
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201926772; hg19: chr7-128490114; API